Analyst Price Targets — CLVT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 7, 2026 11:46 am | Manav Patnaik | Barclays | $2.50 | $2.44 | TheFly | Clarivate price target raised to $2.50 from $2.40 at Barclays |
| January 8, 2026 9:24 am | — | Goldman Sachs | $3.60 | $3.36 | TheFly | Clarivate downgraded to Neutral from Buy at Goldman Sachs |
| December 17, 2025 10:04 am | — | Morgan Stanley | $3.00 | $3.57 | TheFly | Clarivate downgraded to Underweight from Equal Weight at Morgan Stanley |
| October 30, 2025 11:35 am | — | Goldman Sachs | $4.20 | $3.36 | TheFly | Clarivate price target lowered to $4.20 from $4.80 at Goldman Sachs |
| June 13, 2023 2:34 pm | Owen Lau | Oppenheimer | $11.00 | $8.99 | Benzinga | Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts |
| February 6, 2023 5:48 am | — | Morgan Stanley | $12.00 | $11.19 | Benzinga | Morgan Stanley Downgrades Clarivate to Equal-Weight, Raises Price Target to $12 |
| April 19, 2022 10:05 am | — | Goldman Sachs | $20.00 | $17.07 | Benzinga | Goldman Sachs Maintains Buy on Clarivate, Lowers Price Target to $20 |
Latest News for CLVT
LONDON, July 16, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, is proud to support the U.S. Patent and Trademark Office (USPTO) in launching an AI assisted image search within its public trademark search system, TM Search. This new capability allows users to upload and compare images against the U.S. trademark register and has been selected and awarded a…
New cloud-based, shared and scalable platform based on Alma, Primo and Rapido creates a unified library experience Library services, resource sharing and AI-powered discovery in one platform LONDON, July 14, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that the Bibliographic Agency for Higher Education (Abes) has selected the company to…
Clarivate NYSE: CLVT said it has reached an agreement to sell substantially all of its Life Sciences & Healthcare segment to Altaris, an investment firm focused on the healthcare industry, in a transaction valued at $600 million.
LONDON, July 10, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the second quarter 2026 before the market opens on Wednesday, July 29, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at…
Clarivate Plc (CLVT) M&A Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLVT.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.